Healthcare Industry News: Adaptive Radiation Therapy
News Release - November 4, 2013
RaySearch Enters into Distribution Agreement with Hitachi Medical CorporationSTOCKHOLM--(Healthcare Sales & Marketing Network)--RaySearch Laboratories AB (STO:RAYB) has entered into a long-term distribution agreement with Hitachi Medical Corporation (Hitachi) based in Tokyo, Japan. The agreement means that Hitachi will be fully responsible for marketing, sales and service of RaySearch’s proprietary treatment planning system RayStation® on the Japanese market from April 1, 2014.
Japan is one of the largest radiation therapy markets in the world with approximately 700 radiation therapy clinics. Hitachi is a leading distributor of radiation therapy equipment in Japan and represents a wide range of international radiation therapy equipment suppliers. The company was founded in 1949 and has over 5,000 employees globally. Hitachi is highly experienced in the field of radiation therapy treatment planning systems serving 300 Japanese radiation therapy centers with a dedicated sales and support unit with over 30 employees. In addition Hitachi has a broad network of local sales and service staff covering all of Japan.
“Hitachi Medical Corporation is a leading distributor of advanced radiation therapy equipment with a long track record and a large installed base, so we are of course delighted that they have elected to partner with RaySearch. We will now work closely together with Hitachi’s experienced experts to satisfy the needs of the Japanese clinics and I am fully convinced that this collaboration will be highly fruitful for both companies”, says Johan Löf, CEO of RaySearch.”
RayStation® integrates all RaySearch’s advanced treatment planning solutions into a flexible treatment planning system. It combines unique features such as multi-criteria optimization tools with full support for 4D Adaptive Radiation Therapy. It also includes functionality such as RaySearch’s market-leading algorithms for IMRT and VMAT optimization and highly accurate dose engines for photon, electron and proton therapy. The system is built on the latest software architecture and has a graphical user interface offering state-of-the-art usability.
RaySearch Laboratories is a medical technology company that develops advanced software solutions for improved radiation therapy of cancer. RaySearch’s products are mainly sold through license agreements with leading partners such as Philips, Nucletron, IBA, Varian, Accuray and Brainlab. To date, 15 products have been launched through partners and RaySearch’s software is used at over 2,300 clinics in more than 30 countries. In addition, RaySearch offers the proprietary treatment planning system RayStation® directly to clinics. RaySearch was founded in 2000 as a spin-off from Karolinska Institutet in Stockholm and the company is listed in the Small Cap segment on NASDAQ OMX Stockholm.
For more information about RaySearch, visit www.raysearchlabs.com
Source: RaySearch Laboratories
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.